NCT05826509
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05826509
Title SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer (SUGAR)
Acronym SUGAR
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Institut Claudius Regaud
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Chu Angers Angers France Details
CHU Bordeaux Bordeaux France Details
Institut Bergonié Bordeaux France Details
Chu Henri Mondor Créteil France Details
CHU Grenoble Grenoble France Details
Hopital Claude Huriez Lille France Details
CHU Lyon - Hôpital Edouard Herriot Lyon France Details
Institut Paoli-Calmettes Marseille France Details
Hopital Paris Saint-Joseph Paris 75014 France Details
Hopital Bichat - Ap-Hp Paris 75018 France Details
Hopital Europeen Georges-Pompidou Paris France Details
Hopital Pitie Salpetriere Paris France Details
Institut Mutualiste Montsouris Paris France Details
CHU Lyon - Sud Pierre-Bénite France Details
Clinique La Croix Du Sud Quint-Fonsegrives France Details
CHU Rennes Rennes France Details
Hopital Foch Suresnes France Details
CHU Toulouse Toulouse France Details
Institut Universitaire Du Cancer Toulouse - Oncopole Toulouse France Details
Chu Tours - Hopital Bretonneau Tours France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field